Gastric microbiota dysbiosis and Helicobacter pylori infection
- PMID: 37065152
- PMCID: PMC10098173
- DOI: 10.3389/fmicb.2023.1153269
Gastric microbiota dysbiosis and Helicobacter pylori infection
Abstract
Helicobacter pylori (H. pylori) infection is one of the most common causes of gastric disease. The persistent increase in antibiotic resistance worldwide has made H. pylori eradication challenging for clinicians. The stomach is unsterile and characterized by a unique niche. Communication among microorganisms in the stomach results in diverse microbial fitness, population dynamics, and functional capacities, which may be positive, negative, or neutral. Here, we review gastric microecology, its imbalance, and gastric diseases. Moreover, we summarize the relationship between H. pylori and gastric microecology, including non-H. pylori bacteria, fungi, and viruses and the possibility of facilitating H. pylori eradication by gastric microecology modulation, including probiotics, prebiotics, postbiotics, synbiotics, and microbiota transplantation.
Keywords: H. pylori eradication; bacterial interaction; gastric diseases; gastric microecology; microbiota transplant.
Copyright © 2023 Zhang, Zhao and Fu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
Gastrointestinal microbiome and Helicobacter pylori: Eradicate, leave it as it is, or take a personalized benefit-risk approach?World J Gastroenterol. 2022 Feb 21;28(7):766-774. doi: 10.3748/wjg.v28.i7.766. World J Gastroenterol. 2022. PMID: 35317277 Free PMC article.
-
The impact of Helicobacter pylori infection, eradication therapy, and probiotics intervention on gastric microbiota in young adults.Helicobacter. 2021 Dec;26(6):e12848. doi: 10.1111/hel.12848. Epub 2021 Aug 26. Helicobacter. 2021. PMID: 34448282 Clinical Trial.
-
Microbiota in the stomach and application of probiotics to gastroduodenal diseases.World J Gastroenterol. 2022 Dec 21;28(47):6702-6715. doi: 10.3748/wjg.v28.i47.6702. World J Gastroenterol. 2022. PMID: 36620346 Free PMC article. Review.
-
Role of Helicobacter pylori and Other Environmental Factors in the Development of Gastric Dysbiosis.Pathogens. 2021 Sep 16;10(9):1203. doi: 10.3390/pathogens10091203. Pathogens. 2021. PMID: 34578235 Free PMC article. Review.
-
Effect of Helicobacter Pylori Eradication on Human Gastric Microbiota: A Systematic Review and Meta-Analysis.Front Cell Infect Microbiol. 2022 May 4;12:899248. doi: 10.3389/fcimb.2022.899248. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35601105 Free PMC article.
Cited by
-
Anti-urease therapy: a targeted approach to mitigating antibiotic resistance in Helicobacter pylori while preserving the gut microflora.Gut Pathog. 2025 May 28;17(1):37. doi: 10.1186/s13099-025-00708-1. Gut Pathog. 2025. PMID: 40437630 Free PMC article. Review.
-
Distinct microbial signatures of liquid biopsy samples during gastric carcinogenesis and insights from extracellular vesicle analysis.Korean J Intern Med. 2025 Jul;40(4):571-583. doi: 10.3904/kjim.2024.339. Epub 2025 Jul 1. Korean J Intern Med. 2025. PMID: 40635484 Free PMC article.
-
A review for non-antibiotic treatment of Helicobacter pylori: new insight.Front Microbiol. 2024 May 7;15:1379209. doi: 10.3389/fmicb.2024.1379209. eCollection 2024. Front Microbiol. 2024. PMID: 38774508 Free PMC article. Review.
-
Global status and trends of gastric cancer and gastric microbiota research: a bibliometric analysis.Front Microbiol. 2024 Apr 9;15:1341012. doi: 10.3389/fmicb.2024.1341012. eCollection 2024. Front Microbiol. 2024. PMID: 38655079 Free PMC article.
-
Meta-analysis of H. pylori and the gut microbiome interactions and clinical outcomes.Front Cell Infect Microbiol. 2025 Aug 1;15:1610523. doi: 10.3389/fcimb.2025.1610523. eCollection 2025. Front Cell Infect Microbiol. 2025. PMID: 40822578 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources